Carnegie Mellon University key facts
- Carnegie Mellon University is a other based in Pittsburgh, Pennsylvania with 22 tracked portfolio companies.
- Notable positions include Skild AI, Noveome Biotherapeutics, Peca Labs.
- PrivateMarketView records 2 deal participations by Carnegie Mellon University.
- Carnegie Mellon University’s most recent recorded investment was in May 2025 and 1 over two years.
- The team roster lists 34 people.
About Carnegie Mellon University
Carnegie Mellon University is a university based in Pittsburgh, Pennsylvania. Established in 1900, the university is a private research university offering graduate and undergraduate programs across seven colleges spanning engineering, computer science, humanities, business, arts, and public policy. It provides global education through multiple international locations (e.g., Qatar, Silicon Valley, Kigali) and is home to renowned research units such as the Robotics Institute and the National Robotics Engineering Center. Known for pioneering initiatives in artificial intelligence, robotics, and interdisciplinary studies, it serves a diverse student body and faculty. The assets are managed by the board of trustees.
Investment activity
Carnegie Mellon University joined 1 recorded round in the last two years, in line with the 1 in the two years before. By year: 1 in 2025 and 1 in 2024. Carnegie Mellon University most often invests alongside Amazon Alexa Fund (2 shared rounds), Bezos Expeditions (2 shared rounds) and Coatue Management (2 shared rounds). Most recently: Skild AI (Series B, May 2025) and Skild AI (Series A, May 2024).
Carnegie Mellon University portfolio at a glance
22 portfolio companies are on record for Carnegie Mellon University, including Skild AI, Noveome Biotherapeutics and Peca Labs.
12 of the 22 carry a recorded valuation and 1 have recorded secondary-market trades, the names a secondary buyer or seller can price.
Carnegie Mellon University team
34 people are on record at Carnegie Mellon University: 6 partners, 2 managing partners, 1 board member and 25 others. Senior names include Kevin Edwards (Managing Director), Miles Dieffenbach (Managing Director) and Anita Jesionowski (Director). 34 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 22 recorded positions
- ·Watchlist + alerts for Carnegie Mellon University's activity
Portfolio
22 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Skild AI | Other Hardware | ▮ | ▮ | ▮ |
| Noveome Biotherapeutics | — | ▮ | ▮ | ▮ |
| Peca Labs | — | ▮ | ▮ | ▮ |
+ 19 more companies · all 22, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Carnegie Mellon University recent deals
2 recordedMembership and data by Private Market View
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about Carnegie Mellon University
- What companies does Carnegie Mellon University invest in?
- Carnegie Mellon University has 22 recorded portfolio companies, including Skild AI, Noveome Biotherapeutics, Peca Labs.
- Is Carnegie Mellon University actively investing?
- Carnegie Mellon University's most recent recorded investment was in May 2025.